May 23, 2025

uniQure N.V. (QURE) Stock Analysis: Exploring a 133.81% Potential Upside in Biotechnology

As the biotechnology sector continues to capture investor attention, uniQure N.V. (NASDAQ: QURE) emerges as a compelling player with significant growth potential. Based in Amsterdam, Netherlands,..

Geron Corporation (GERN): Investor Outlook Highlights a 149% Potential Upside in the Biotech Sector

Geron Corporation (NASDAQ: GERN), a key player in the biotechnology sector, is capturing investor attention with its substantial potential upside of 149.16%. This California-based biopharmaceutical company..

Intellia Therapeutics (NTLA) Stock Analysis: A Potential 325% Upside in Gene Editing Biotech

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering entity in the biotechnology sector, is currently capturing investor interest with its intriguing potential for significant upside. Despite a..

Ardelyx, Inc. (ARDX) Stock Analysis: Exploring a 172% Upside Potential in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX) stands as an intriguing prospect within the biotechnology sector, primarily driven by its innovative approach to addressing unmet medical needs. With a..

Avanos Medical, Inc. (AVNS) Stock Analysis: Exploring 12.18% Potential Upside Amid Challenging Market Dynamics

Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical device industry, is currently navigating through a landscape characterized by both opportunities and challenges. With..

GH Research PLC (GHRS): Biotechnology with a Potential 206% Upside – Investor Insights

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company based in Dublin, Ireland, is capturing the attention of investors with its ambitious approach to treating depression..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring the 82% Upside Potential in Biotech Innovations

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector with its innovative approach to immunology..

CureVac N.V. (CVAC) Stock Analysis: Exploring a 51% Upside in the mRNA Space

CureVac N.V. (CVAC), a pioneering biopharmaceutical company specializing in mRNA technology, has been making waves in the biotechnology sector with its innovative approach to developing transformative..

Iovance Biotherapeutics, Inc. (IOVA): Exploring a Potential 511% Upside in Biotech Innovation

For investors with a keen interest in the biotechnology sector, Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) represents an intriguing opportunity, particularly given its ambitious potential upside of..

Evolus, Inc. Common Stock (EOLS)

⚠️ No article content returned.

..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating a Potential 7.53% Upside Amid Healthcare Challenges

Community Health Systems, Inc. (NYSE: CYH) stands as a significant player in the healthcare sector, operating a network of general acute care hospitals across the United..

InnovAge Holding Corp. (INNV) Stock Analysis: Evaluating a 24.38% Upside Potential in Healthcare

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, is gaining attention among investors due to its significant upside potential. With a current..

Dianthus Therapeutics, Inc. (DNTH) Investor Outlook: Exploring a 179.96% Potential Upside in Biotechnology

For investors eyeing the healthcare sector, Dianthus Therapeutics, Inc. (NASDAQ: DNTH) offers an intriguing opportunity, particularly in the dynamic biotechnology industry. Headquartered in New York, this..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a Potential 248% Upside in the Biotech Sector

Nuvation Bio Inc. (NUVB) is capturing the attention of investors with a remarkable potential upside of 248.15%, according to analyst ratings. Operating within the dynamic biotechnology..

Beta Bionics, Inc. (BBNX) Stock Analysis: Potential 61% Upside in the Healthcare Sector

Beta Bionics, Inc. (BBNX), a promising player in the healthcare sector, is steadily capturing investor interest with its innovative solutions in the medical devices industry. Specializing..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring a Promising 43.45% Potential Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH) stands out in the medical devices industry with its innovative approach to treating liver cancers. Known for its HEPZATO KIT, this..

Gyre Therapeutics, Inc. (GYRE) Investor Outlook: Unpacking the 78.41% Potential Upside

In the ever-evolving landscape of the biotechnology sector, Gyre Therapeutics, Inc. (NASDAQ: GYRE) has positioned itself as a notable player, developing innovative therapies to combat debilitating..

Immunome, Inc. (IMNM) Stock Analysis: Unpacking the 189.60% Potential Upside

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology firm, is making waves in the healthcare sector with a promising pipeline aimed at developing targeted cancer therapies. With..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a Promising 58% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ) is generating significant buzz among investors, promising a potential upside of 58.13%. This biopharmaceutical company, headquartered in Solana Beach, California, is..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Exploring a Biotech Gem with 12.20% Potential Upside

Niagen Bioscience, Inc. (NAGE), a Los Angeles-based biotech company specializing in healthy aging products, has been catching the eye of investors with its promising potential upside..

Search

Funds

May 23, 2025

Search

Funds

May 23, 2025

FTSE 100

Funds